...
首页> 外文期刊>癌と化学療法 >An outpatient with unresectable pancreatic cancer treated with gemcitabine showing prolonged NC (22 months)
【24h】

An outpatient with unresectable pancreatic cancer treated with gemcitabine showing prolonged NC (22 months)

机译:具有吉西他滨治疗的不可切除的胰腺癌的门诊显示延长的NC(22个月)

获取原文
获取原文并翻译 | 示例

摘要

A 76-year-old man developed jaundice and was hospitalized in January 2002. A 3 cm tumor was found in the head of the pancreas by abdominal CT, and the patient underwent laparotomy. The tumor was histologically diagnosed as a well-differentiated adenocarcinoma, and showed extensive invasion to the portal vein (T4NXM 0 Stage IV a). Incisional biopsy and hepaticojejunostomy were performed. On the basis of a drug sensitivity test, chemotherapy with 800 mg/m2/week gemcitabine was administered. The patient showed prolonged NC without any symptoms for 22 months, although the CEA and DUPAN-2 levels gradually increased during this time and massive ascites were detected in a routine abdominal CT at 22 months postsurgery. The patient died after 25 months of chemotherapy. Here we report a case of unresectable pancreatic cancer treated with gemcitabine on the basis of a drug sensitivity test.
机译:一名76岁的男子开发了黄疸,并于2002年1月住院。腹部CT的胰腺头部发现3厘米的肿瘤,患者接受了剖腹手术。 肿瘤在组织学上被诊断为良好分化的腺癌,并且对门静脉(T4NXM 0阶段IV A)进行了广泛的侵袭。 进行了入侵活检和肝病jejunostomy。 在药物敏感性试验的基础上,施用了800mg / m2 /周的化疗。施用吉西他滨。 患者显示延长的NC没有任何症状22个月,尽管在此时间内CEA和Dupan-2水平逐渐增加,并且在22个月后在常规腹部CT中检测到巨大的腹水。 患者在25个月的化疗后死亡。 在这里,我们在药物敏感性试验的基础上报告了用吉西他滨治疗的不可切除的胰腺癌的病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号